Filed by Genesis Microchip Incorporated Pursuant to Rule 425
                                                Under the Securities Act of 1933
                                        And Deemed Filed Pursuant to Rule 14a-12
                                       Under the Securities Exchange Act of 1934
                                                    Subject Company:  Sage, Inc.
                                                   Commission File No.:  1-16529

This filing relates to a planned merger (the "Merger") between Genesis Microchip
Incorporated ("Genesis") and Sage, Inc. ("Sage") pursuant to the terms of an
Agreement and Plan of Merger and Reorganization, dated as of September 27, 2001
(the "Merger Agreement"), by and between Genesis and Sage. The Merger Agreement
is on file with the Securities and Exchange Commission as an exhibit to the
Current Report on Form 8-K filed by Genesis on September 28, 2001, and is
incorporated by reference into this filing.

The following is a Q&A sheet that was utilized by Genesis and Sage in connection
with a joint conference call with financial analysts on September 28, 2001:

Strategic Benefits
------------------

1.   Amnon - Why did you feel the need to do this deal?

     A:   This transaction brings together two innovative companies in the
          display semiconductor industry. Together, the two companies should be
          able to significantly step-up their pace of innovation and offer their
          customers a more complete portfolio of display semiconductor
          solutions, helping to build on already strong momentum at both
          companies. The merger combines very complementary R&D, manufacturing
          and global distribution channels of each company to create the size,
          scale and scope we need to provide rapid and innovative solutions for
          our customers as this industry explodes.

          Genesis continues to enjoy strong momentum and good visibility in its
          business. At the same time, Sage has also demonstrated significant
          positive momentum in its business. Genesis's management did not feel a
          "need to do this deal." Rather, Genesis was presented with an
          opportunity to build on its already strong momentum by adding a set of
          complementary products and technologies.

2.   Technology or product benefits. Technology overlap between the two
     companies

     A:   Although Genesis and Sage both manufacture display semiconductors,
          Genesis's strength is in the analog and dual interface, while Sage's
          strength is in the digital-only flat panel monitor markets. Together,
          the two companies will be able to offer a more complete portfolio of
          display semiconductor solutions to their customers. In addition, Sage
          has a leading position in semiconductors for consumer devices through
          its acquisition of Faroudja. Combining the two companies'
          complementary design technologies and R&D teams will provide the size,
          scale and scope to rapidly develop new innovative products in this
          growing industry.



3.   Are there concerns about trends in the industry or Genesis's future
     competitive position that made this deal important to do?

     A:   Genesis continues to enjoy strong momentum and good visibility in its
          business. Sage has recently demonstrated similar momentum. Together,
          the two companies believe that they will be able to build on this
          momentum and be poised to more effectively compete against our large
          diversified competitors as well as specialist niche players and new
          entrants. Both companies believe that this combination will better
          prepare the combined entity for the future as the display IC industry
          continues to evolve.

4.   The price seems a bit high. Can you comment?

     A:   The price of $15.59 per share represents a premium of 37% to Sage's
          closing price yesterday. However, we believe that because of the
          strategic nature of the transaction and the significant continuing
          ownership of Sage's stockholders in the combined entity, the more
          appropriate measure to evaluate is the relative ownership in the
          combined entity. The exchange ratio of 0.571 represents an ownership
          level of 28% for Sage shareholders. This exchange ratio represents a
          16% premium to the average exchange ratio over the past 10 trading
          days.

5.   Chandra, why did they feel the need to do this deal?

     A:   Sage has done an excellent job executing its business plan, has
          demonstrated the strength of its business in the past quarter and
          continues to believe that it can build on this momentum in the future.
          However, Sage's management and board saw the opportunity to combine
          with Genesis as a chance to further build on each company's momentum
          while preserving the potential for future upside through a significant
          continuing equity interest for Sage stockholders. The ability to
          achieve the size, scale and scope necessary to effectively compete in
          the next stage of the industry's evolution and the notion of combining
          our complementary technology strengths was too compelling to resist.

6.   How do you think your customers will react to this deal?

     A:   We believe that our customers are increasingly looking for a broader
          portfolio of solutions from their suppliers. As such, our combined
          product portfolio should help us to further meet our customers' needs.
          Moreover, our combined strength in R&D will better enable us to meet
          our customers' technology needs and provide a much better support now
          as the industry rapidly evolves.

7.   Will the customers bring-in another supplier where there is a meaningful
     overlap?

     A:   We do not believe that there is significant customer overlap between
          Genesis and Sage. Specifically, Sage has a strong presence in the
          digital-only flat panel monitor market, while Genesis strength is the
          analog-only and dual interface products. Every new design cycle,
          customers look for the best solution available. Combining the two



          companies will increase our ability to provide the best solution to
          our customers and provide better support to get our customers to
          production.

8.   How do you think your competitors will react to this deal?

     A:   Difficult to say. I guess that they will, like we, have to step up
          their R&D efforts and continue to improve the quality of their
          products. We also expect that they will attempt to make a "second
          source" argument to some of our larger customers. However, we do not
          anticipate any significant problems. In terms of our large-cap
          competitors such as STMicro, Philips, Macronix and others, this
          transaction will help us better compete on manufacturing and
          distribution while staying ahead of the technology curve.

Financial
---------

9.   Earnings improvement - revenue upside or cost savings?

     A:   In the near-term, more of the synergies will come from the expense
          side. Over time, however, we expect that the combined entity will be
          successful in further penetration of other high growth segments of the
          display IC market, such as Progressive Scan TV, LCD TV and projectors.

10.  Can you be more specific regarding anticipated synergies?

     A:   We have defined our plan in broad terms. The cost savings will come
          from multiple areas: purchasing and manufacturing; consolidation of
          the sales channels; redundant public company costs; optimizing the
          combined company's facilities usage in California; and duplicated
          market communication expenses. In addition, we expect that the
          combined entity will be successful in further penetration of other
          high growth segments of the display IC market, such as LCD-TV, digital
          TV and projectors.

11.  What will be the combined entity's long-term business model? Margins, how
     long?

     A:   Over time, we expect that the combined company will be able to achieve
          operating margins at or above Genesis's current operating results. We
          will provide more direct guidance in the future in accordance with
          Genesis's customary practices.

12.  Describe the combined entity's potential to achieve top-line synergies.

     A:   In the near-term, more of the synergies will come from the expense and
          cost side. Over time, however, we expect that the combined entity will
          be successful in further penetration of other high growth segments of
          the display IC market, such as digital TV, LCD TV and projectors.



13.  Customer overlap, what will happen to combined revenues?

     A:   We do not believe that there is significant customer overlap between
          Genesis and Sage. Specifically, Sage has a strong presence in the
          digital-only flat panel monitor market, while Genesis strength is in
          the dnalog-only and the dual interface products. We believe that the
          strength of our combined customer service and support organization,
          coupled with even greater technological innovation, will help mitigate
          any of these perceived issues.

14.  Describe more specifically where cost synergies will come from. How quickly
     will they be achieved?

     A:   Generally, cost synergies will come from three areas. The first will
          be G&A reductions from elimination of duplicative functions, including
          areas such as audit and insurance. The second will be from
          transitioning Sage's sales and distribution model to Genesis's, which,
          with less reliance on representatives and distributors, is a lower
          cost solution. The third will be manufacturing efficiencies resulting
          from higher combined production volumes. Moreover, we anticipate that
          redeployment of some existing resources will have a positive impact on
          our performance. We anticipate that these synergies will be achieved
          soon after the closing of the transaction.

15.  Are you confident that you can achieve the synergies described? Do you
     already have a specific plan to do so?

     A:   The management teams of both companies have identified key areas for
          top-line synergies, cost reductions and resource redeployment and can
          express a high degree of confidence in the synergies detailed here
          today. A specific plan has been developed and will be further refined
          between announcement and closing.

16.  How does this deal add to your longer-term financial performance?

     A:   We anticipate that the combined entity will be able to better satisfy
          our customers' needs, penetrate new segments of the display IC market
          and operate more efficiently. This should naturally lead to strong
          performance over the long-term.

17.  How is the quarter shaping up?

     A:   We recently provided updated guidance for the September quarter. With
          respect to our financial performance, we will next update guidance
          with the release of our fiscal second quarter results.



Transaction Details
-------------------

     18.  Why the need for the change of legal domicile? What are the
          implications for the future? Does this change the tax model going
          forward?

     A:   This is being done to facilitate our ability to effect acquisitions of
          U.S. companies in a tax-free manner for acquiree stockholders. We
          believe that there will be no material change to our effective tax
          rate over the next few years.

19.  When do you anticipate the deal closing? Will the change of Genesis's legal
     domicile potentially slow this up?

     A:   Assuming no other delays, we believe that the transaction will close
          by the end of December. Given that the change of Genesis's legal
          domicile will occur simultaneously with the transaction, we do not
          anticipate any delay to result from the change.

20.  Chandra - Is there a collar provided for in the transaction?

     A:   No.

21.  Where will the combined company's headquarters be?

     A:   The combined company's headquarters will be in Alviso, California.

22.  How active will Sage's CEO be in day-to-day operations? What will be the
     makeup of senior management between the two companies?

     A:   The combined company's board will have seven members, with five
          members of the Genesis board and two members of the Sage board
          joining. Chandra will be on the board as Vice Chairman. He will be
          active in day-to-day management as Executive Vice President of
          Engineering. Eric Erdman will continue as CFO of Genesis.

23.  Chandra - Will any options accelerate as a result of the transaction?

     A:   Generally, no. However, there is a small number of options that do
          accelerate upon a change of control.

24.  Chandra - Was there any interest from other third parties in acquiring
     Sage?

     A:   It is our company's policy not to comment on such matters.

25.  What are the significant conditions to closing?

     A:   Conditions to closing include regulatory and shareholder approvals,
          the completion of the change of Genesis's legal domicile to the United
          States and other customary



closing conditions. For more details, please refer to the merger agreement when
it becomes available.

26.  Is there a break-up fee? How much is it?

     A:   The merger agreement has customary termination provisions. For more
          details, please refer to the merger agreement when it becomes
          available.

Additional Information about the Merger and Where to Find It

Genesis and Sage intend to file a registration statement, joint proxy
statement/prospectus and other relevant materials with the SEC in connection
with the Merger. The joint proxy statement/prospectus will be mailed to the
stockholders of Genesis and Sage. Investors and security holders of Genesis and
Sage are urged to read the joint proxy statement/prospectus and the other
relevant materials when they become available because they will contain
important information about Genesis, Sage and the Merger. The joint proxy
statement/prospectus and other relevant materials (when they become available),
and any other documents filed by Genesis or Sage with the SEC, may be obtained
free of charge at the SEC's web site at www.sec.gov. In addition, investors and
security holders may obtain free copies of the documents filed by Genesis with
the SEC by contacting Genesis Investor Relations, 2150 Gold Street, Alviso, CA
95002, (408) 262-6599. Investors and security holders may obtain free copies of
the documents filed by Sage with the SEC by contacting Sage Investor Relations,
1601 McCarthy Blvd, Milpitas, California 95030, (408) 383-5300. Investors and
security holders are urged to read the joint proxy statement/prospectus and the
other relevant materials when they become available before making any voting or
investment decision with respect to the Merger.

Genesis and its directors, Alexander S. Lushtak, Amnon Fisher, Jeffrey Diamond,
James E. Donegan, George A. Duguay, and Lawrence G. Finch, may be deemed to be
participants in the solicitation of proxies from the stockholders of Genesis in
favor of the Merger. In addition, the officers of Genesis may be deemed to be
participants in the solicitation of proxies from the stockholders of Genesis in
favor of the Merger. The following individuals are officers of Genesis: Robert
Bicevskis, Chief Technology Officer; Tzoyao Chan, Vice President, Product
Development; Eric Erdman, Chief Financial Officer and Secretary; Anders Frisk,
Vice President, Marketing; Ken Murray, Vice President, Human Resources; Matthew
Ready, Vice President, Sales; and Mohammad Tafazzoli, Vice President,
Operations. A description of the interests in Genesis of its directors and
officers is set forth in Genesis's proxy statement for the 2001 Annual Meeting
of Stockholders of Genesis, which was filed with the SEC on August 24, 2001.